Jill M. Broadfoot
2009 - Vical
In 2009, Jill M. Broadfoot earned a total compensation of $546K as Senior Vice President, Chief Financial Officer and Secretary at Vical, a 16% increase compared to previous year.
Compensation breakdown
| Bonus | $115,000 |
|---|---|
| Option Awards | $81,686 |
| Salary | $284,000 |
| Stock Awards | $60,200 |
| Other | $5,091 |
| Total | $545,977 |
Broadfoot received $284K in salary, accounting for 52% of the total pay in 2009.
Broadfoot also received $115K in bonus, $81.7K in option awards, $60.2K in stock awards and $5.1K in other compensation.
Rankings
In 2009, Jill M. Broadfoot's compensation ranked 6,544th out of 9,885 executives tracked by ExecPay. In other words, Broadfoot earned more than 33.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,544 out of 9,885 | 34th |
Division Manufacturing | 2,391 out of 3,690 | 35th |
Major group Chemicals And Allied Products | 526 out of 866 | 39th |
Industry group Drugs | 357 out of 638 | 44th |
Industry Biological Products, Except Diagnostic Substances | 72 out of 133 | 46th |
Source: SEC filing on April 13, 2012.
Broadfoot's colleagues
We found two more compensation records of executives who worked with Jill M. Broadfoot at Vical in 2009.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019